[Evaluation of the combination of atenolol and indapamide in the therapy of arterial hypertension (with data concerning toxicity and tolerance in the experimental animal)].
D000328:Adult; D000368:Aged; D000818:Animals; D001262:Atenolol / Q000008:administration & dosage* / Q000009:adverse effects; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004232:Diuretics / Q000008:administration & dosage*; D004285:Dogs; D004359:Drug Therapy, Combination; D004573:Electrolytes / Q000097:blood; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007190:Indapamide / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000008:administration & dosage*; D051381:Rats
D004232:Diuretics; D004573:Electrolytes; D011412:Propanolamines; D001262:Atenolol; D007190:Indapamide
Valutazione dell'associazione atenololo-indapamide nella terapia dell'ipertensione arteriosa (con dati di tossicitá e tollerabilitá nell'animale da esperimento.